899 related articles for article (PubMed ID: 19805956)
1. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
[TBL] [Abstract][Full Text] [Related]
2. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
3. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
[TBL] [Abstract][Full Text] [Related]
4. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
5. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
[TBL] [Abstract][Full Text] [Related]
6. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
[TBL] [Abstract][Full Text] [Related]
7. Azole susceptibility and resistance in Candida dubliniensis.
Pinjon E; Moran GP; Coleman DC; Sullivan DJ
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
[TBL] [Abstract][Full Text] [Related]
8. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection.
Faggi E; Pini G; Campisi E; Martinelli C; Difonzo E
Mycoses; 2005 May; 48(3):211-5. PubMed ID: 15842340
[TBL] [Abstract][Full Text] [Related]
9. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.
Giammanco GM; Pecorella S; Distefano S; Pecoraro V; Milici ME; Pizzo G
New Microbiol; 2001 Oct; 24(4):397-404. PubMed ID: 11718378
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification of fluconazole resistance using Chrom agar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
13. Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon.
Dos Santos Abrantes PM; McArthur CP; Africa CW
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):222-7. PubMed ID: 24726686
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Migliorati CA; Birman EG; Cury AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
[TBL] [Abstract][Full Text] [Related]
15. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
Mokaddas E; Khan ZU; Ahmad S
Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
[TBL] [Abstract][Full Text] [Related]
18. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
Ahmad S; Mokaddas E; Al-Sweih N; Khan ZU
Med Princ Pract; 2005; 14 Suppl 1():77-83. PubMed ID: 16103717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
